21 Nov 2012

UCB and NewBridge Pharmaceuticals Partner for Middle East and African markets

Read More
19 Nov 2012

UCB commences phase 3 lacosamide study in Asia

Read More
14 Nov 2012

RAPID™-PsA study showed that certolizumab pegol improved signs and symptoms of psoriatic arthritis in patients with and without prior anti-TNF exposure

Read More
13 Nov 2012

UCB announces data on Cimzia® (certolizumab pegol) for patients with moderate to severe rheumatoid arthritis at American College of Rheumatology 2012 Congress

Read More
13 Nov 2012

RAPID™-axSpA study showed certolizumab pegol reduced signs and symptoms of axial spondyloarthritis

Read More
12 Nov 2012

Have you made a difference for people with epilepsy through journalism? Final call for entries to the 2012 Excellence in Epilepsy Journalism Award

Read More
9 Nov 2012

New data from UCB’s immunology portfolio highlighted at 2012 American College of Rheumatology Meeting

Read More
29 Oct 2012

UCB Interim Report for the first nine months of 2012

Read More
12 Oct 2012

UCB announces retirement of Executive Vice President and General Counsel and appointment of successor

Read More
11 Oct 2012

UCB scientist awarded visiting professorship at Oxford Medical School

Read More
Subscribe to